NCCN is helping improve access to continuing medical education (CME) programs with the launch of a mobile application for a recent program based on the NCCN Guidelines Update Webinar Series™: Kidney Cancer. This is the first NCCN CME program available through a mobile interface, made possible through collaboration with QuantiaMD. The CME activity contains a brief, yet comprehensive presentation by Robert A. Figlin, MD, Chair, Division of Medical Oncology and Therapeutics Research at City of Hope Comprehensive Cancer Center, in which he highlights recent updates made to the NCCN Clinical Practice Guidelines in Oncology® for Kidney Cancer. Through this new application, the presentation can be watched on QuantiaMD’s online physician community which is easily accessed via a mobile device (including iPhone, Android or Blackberry) or on the web.
Dr. Figlin’s presentation initially ran as a series of webinars as part of a new educational initiative developed by NCCN, the NCCN Guidelines Update Webinar Series™. The webinars consisted of a presentation by Dr. Figlin discussing issues considered by the NCCN Guidelines Panel that resulted in changes to the NCCN Guidelines for Kidney Cancer, comparing new data with existing standards of care, and reviewing significant studies that support modification of the panels’ recommendations. The webinars were very well-received with more than 650 participants actively engaged in the activity.
Following Dr. Figlin’s presentation, the webinars included an interactive question and answer period for participants. Recognizing the value of interaction among participants, the QuantiaMD mobile platform also allows clinicians to ask questions of each other and comment to other participants who are verified as clinicians through the QuantiaMD community, directly from the interactive mobile activity.
QuantiaMD also hosts a second NCCN video activity on risk-based breast cancer screening presented by Therese B. Bevers, MD, Chair of the NCCN Breast Cancer Screening & Diagnostic Guidelines Panel and Professor of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center. Dr. Bevers provides an overview of what the NCCN Guidelines® recommend in terms of breast cancer screening, a topic that continues to remain popular in the news and within public forums.
To view Dr. Figlin’s segment on Kidney Cancer Guidelines or Dr. Bever’s segment on Breast Cancer Screening, go to www.quantiamd.com/nccn. For more information about QuantiaMD, including how to download QuantiaMD to your mobile device, go to www.quantiamd.com/about.